Inhaled Nitric Oxide Delivery Systems Market

Future Market Insights

Key Insight

The inhaled nitric oxide delivery systems market is projected to grow from USD 390.3 million in 2025 to USD 967.3 million by 2035, at a CAGR of 9.5%. Pediatrics will dominate with a 57.3% market share, while hypoxic respiratory failure (hrf) will lead the application segment with a 48.6% share.

August 04, 2025

Anurag Sharma

250 Pages

Cite this Report

Inhaled Nitric Oxide Delivery Systems Market

https://www.futuremarketinsights.com/reports/inhaled-nitric-oxide-delivery-systems-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Mallinckrodt Pharmaceuticals
Getinge
VERO Biotech
LINDE
Beyond Air
SLE
NU MED
Bellerophon Therapeutics
Air Liquide Healthcare
Circassia Pharmaceuticals

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Inhaled Nitric Oxide Delivery Systems Market

Key Players

Similar Industry Reports